<DOC>
	<DOCNO>NCT02183909</DOCNO>
	<brief_summary>The overall goal CRUSH project enhance extend response local HIV/AIDS epidemic Alameda County set innovative , evidence-based intervention across continuum HIV prevention care , target individual community vulnerable HIV . The East Bay AIDS Center , partnership University California San Francisco 's Center AIDS Prevention Studies , Gladstone Institutes , several key community-based organization , engage participatory partnership enhance implement HIV service target East Bay 's high risk population- young men sex men ( Y/MSM ) . Specifically , CRUSH Project design evaluate combination program approach address sexual health care need young gay men color sexual partner enhance current program activity Downtown Youth Clinic ( DYC ) . We hypothesize reduce impact HIV among Y/MSM expand current DYC service structure two way . We intend expand HIV testing , linkage retention care youth test HIV positive , provide intensive risk-reduction counsel antiretroviral treatment , thereby ultimately reduce risk HIV transmission . And intend first time offer comprehensive combination package preventive service HIV-negative youth , include routine access HIV/STI screen treatment , access HIV pre-exposure prophylaxis ( PrEP ) . The CRUSH Project also substudy enroll HIV-negative participant eligible receive PEP . The substudy evaluate tolerability acceptability 28 day course Stribild® give post-exposure prophylaxis ( PEP ) prevent sexual acquisition HIV-1 Y/MSM color .</brief_summary>
	<brief_title>Connecting Resources Urban Sexual Health</brief_title>
	<detailed_description>The CRUSH Project ( Connecting Resources Urban Sexual Health ) demonstration project Alta Bates Summit Medical Center 's East Bay AIDS Center ( EBAC ) Downtown Youth Clinic ( DYC ) offer intervention aim reduce HIV-1 incidence among young MSM color East Bay region . CRUSH two major component : 1 . Providing enhanced test linkage care ( TLC+ ) HIV positive , aim increase proportion HIV positive Y/MSM care , virologically suppress , receive intensive risk reduction counsel . 2 . Providing comprehensive sexual health service high risk HIV-negatives , include limited provision PrEP PEP clinically appropriate . In addition , CRUSH Project offer substudy CRUSH , enroll HIV negative CRUSH participant eligible receive PEP . Stribild® single-tablet , four-drug , once-daily complete regimen FDA-approved treatment HIV-1 infection treatment-naïve HIV-infected adult estimate glomerular filtration rate ≥70ml/min/1.73m2 . Because limited data , antiretroviral drug combination drug approve PEP . Current PEP guideline generally call use 28-day course 3-drug regimen approve treatment HIV-1 infection</detailed_description>
	<mesh_term>Sexually Transmitted Diseases</mesh_term>
	<mesh_term>Elvitegravir , Cobicistat , Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<criteria>Men age 1829 ever sexually active men ; Transgender female ( M2F ) age 1829 sexually active men ; Transgender male ( F2M ) age 1829 sexually active men ; Any HIVnegative person age 1829 , male female , least one know HIV positive ( i.e . serodiscordant ) sexual partner . For PEP substudy inclusion criterion least one episode 72 hour prior presentation unprotected receptive anal intercourse partner know suspect HIV positive follow substudy exclusion criterion : Known kidney disease Dipstick proteinuria &gt; 1+ eGFR &lt; 70 ml/min/1.73m2 Known metabolic bone disease Signs symptoms acute HIV infection Concomitant use nephrotoxic drug medication contraindicate Stribild®</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>29 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>